Accumulated Depreciation Lease AssetsPPE、Compensation For TransferEI、四半期包括利益他2件
- 【期間】
| 年度 | Accumulated Depreciation Lease AssetsPPE | Compensation For TransferEI | 四半期包括利益 | 当期経常利益 | Research And Development Expenses Research And Development Activities - Life Science Reportable Segment Member |
|---|
| 2010/09 | - | | - | | -1.72億 | | 59.8億 | | - | |
| 2011/09 | - | | - | | 25.5億 | 黒転 | 56億 | -6.2% | - | |
| 2012/09 | - | | - | | -46.7億 | 赤転 | -19.8億 | 赤転 | - | |
| 2013/09 | - | | - | | 63.6億 | 黒転 | 60.9億 | 黒転 | - | |
| 2014/09 | - | | - | | -791億 | 赤転 | 82.8億 | +35.9% | - | |
| 2015/09 | - | | - | | 19.2億 | 黒転 | 52.6億 | -36.5% | - | |
| 2016/09 | - | | - | | 170億 | +782.2% | 145億 | +175.7% | - | |
| 2017/09 | - | | - | | 69.4億 | -59.1% | 157億 | +8.2% | - | |
| 2018/09 | - | | - | | 126億 | +81.9% | 155億 | -1.4% | - | |
| 2019/09 | - | | - | | 93.6億 | -25.9% | 136億 | -11.8% | - | |
| 2020/09 | - | | - | | 117億 | +25% | 125億 | -8.4% | - | |
| 2021/09 | - | | - | | 94.5億 | -19.2% | 120億 | -4% | - | |
| 2022/09 | - | | - | | 76.1億 | -19.5% | 109億 | -9.4% | - | |
| 2023/09 | - | | - | | 113億 | +48.8% | 89.6億 | -17.6% | - | |
